|
GYG1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.87609999999983E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.28399999999684E-05 |
| Normal-vs-Stage2 |
9.807800E-02 |
| Normal-vs-Stage3 |
2.103700E-02 |
| Normal-vs-Stage4 |
8.944300E-03 |
| Stage1-vs-Stage2 |
3.595800E-01 |
| Stage1-vs-Stage3 |
2.421000E-01 |
| Stage1-vs-Stage4 |
6.927800E-01 |
| Stage2-vs-Stage3 |
9.642800E-01 |
| Stage2-vs-Stage4 |
3.531600E-01 |
| Stage3-vs-Stage4 |
2.694800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.19530000000035E-05 |
| Normal-vs-AfricanAmerican |
5.356000E-02 |
| Normal-vs-Asian |
2.835200E-03 |
| Caucasian-vs-AfricanAmerican |
8.915800E-01 |
| Caucasian-vs-Asian |
6.222000E-01 |
| AfricanAmerican-vs-Asian |
6.286400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.498400E-03 |
| Normal-vs-Female |
3.69310000000178E-05 |
| Male-vs-Female |
4.862400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.04910000000314E-05 |
| Normal-vs-Age(41-60Yrs) |
1.784750E-03 |
| Normal-vs-Age(61-80Yrs) |
3.799500E-02 |
| Normal-vs-Age(81-100Yrs) |
6.330200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.453200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.724350E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.969200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.622000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.328800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.790200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.918400E-01 |
| Classical-VS-Follicular |
4.157200E-04 |
| Classical-VS-Other |
1.245370E-01 |
| Classical-VS-Normal |
2.67959999966649E-07 |
| Tall-VS-Follicular |
6.624700E-03 |
| Tall-VS-Other |
1.013800E-01 |
| Tall-VS-Normal |
1.237510E-03 |
| Follicular-VS-Other |
9.082000E-01 |
| Follicular-VS-Normal |
8.615200E-01 |
| Other-VS-Normal |
9.566600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.081900E-03 |
| Normal-vs-N1 |
1.980030E-01 |
| N0-vs-N1 |
7.959000E-01 |
|
|
